Sorrento Therapeutics (SRNE) News Today → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free SRNE Stock Alerts $0.0002 -0.01 (-98.33%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | americanbankingnews.comSorrento Therapeutics (NASDAQ:SRNE) Research Coverage Started at StockNews.comApril 26, 2024 | morningstar.comSorrento Therapeutics Inc SRNEMarch 12, 2024 | wsj.comJudge Declines to Dismiss Sorrento Therapeutics Bankruptcy CaseFebruary 27, 2024 | tmcnet.comVirpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.February 27, 2024 | businesswire.comVirpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.February 9, 2024 | marketbeat.comSorrento Therapeutics (NASDAQ:SRNE) Stock Price Passes Below 200 Day Moving Average of $0.11Sorrento Therapeutics (NASDAQ:SRNE) Stock Crosses Below 200 Day Moving Average of $0.11January 9, 2024 | finance.yahoo.comSorrento Therapeutics, Inc. (0L85.L)November 5, 2023 | morningstar.comSorrento Therapeutics Inc SRNEQOctober 14, 2023 | yahoo.comSorrento, Italy - Weather Forecasts | Maps | News - Yahoo WeatherSeptember 7, 2023 | bizjournals.comCourt rules Virpax CEO Anthony Mack breached his agreement with Sorrento TherapeuticsAugust 8, 2023 | finance.yahoo.comSorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse BidJuly 13, 2023 | msn.comWildcat Claims CNSL Shareholders Are Being Ripped Off in Weak Deal, Claiming $14 Price is RequiredJuly 5, 2023 | seekingalpha.comSorrento sees promising phase 2 results for abivertinib for lymphomaJune 22, 2023 | seekingalpha.comSRNEQ Sorrento Therapeutics, Inc.June 14, 2023 | fool.comSorrento Therapeutics (OTC: SRNE.Q)June 6, 2023 | marketbeat.comUBS Group AG Has $2.12 Million Stock Position in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)UBS Group AG increased its stake in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 916.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,383,825 shares of the biopharmaceutical company's stock after acquiring an addiApril 24, 2023 | finance.yahoo.comSorrento Therapeutics, Inc. (SRNEQ)March 21, 2023 | wsj.comSorrento Therapeutics Opponent Loses Chapter 11 Committee SeatMarch 18, 2023 | wsj.comFirm Retention Summary: Sorrento Therapeutics Inc.March 15, 2023 | thestreet.comWhy Sorrento Therapeutics (SRNE) Stock Plummeted TodayMarch 8, 2023 | marketbeat.comSorrento Therapeutics, Inc. (NASDAQ:SRNE) Shares Bought by Credit Suisse AGCredit Suisse AG grew its holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 260.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,026,474 shares of the biopharmaceutical company's stock after buyingMarch 2, 2023 | finance.yahoo.comIs a Surprise Coming for Sorrento Therapeutics (SRNEQ) This Earnings Season?February 27, 2023 | finance.yahoo.comScilex Holding Company announces the commercial launch of ELYXYBTM (celecoxib oral solution) in the U.S., strengthening its leadership position in non-opioid pain managementFebruary 22, 2023 | benzinga.comWhy Sorrento Therapeutics Stock Is Soaring TodayFebruary 22, 2023 | yahoo.comBankrupt Sorrento Therapeutics Secures Court Approval for $75M FinancingFebruary 22, 2023 | seekingalpha.comSorrento Therapeutics surges 28% as court nods for a $75M loanFebruary 21, 2023 | finance.yahoo.comSorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 CaseFebruary 18, 2023 | finance.yahoo.comSorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)February 17, 2023 | benzinga.comThinking about buying stock in Esports Entertainment, Marathon Digital, Sorrento Therapeutics, Nu Holdings, or ContextLogic?February 15, 2023 | finance.yahoo.comWhy Kim Jong Un’s Daughter Is All Over North Korean MediaFebruary 14, 2023 | finance.yahoo.comSorrento Therapeutics (SRNE) Loses -77.24% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerFebruary 14, 2023 | uk.finance.yahoo.comSorrento Therapeutics Files For BankruptcyFebruary 13, 2023 | seekingalpha.comHot Stocks: TDC climbs on earnings; FSLY upgrade; TWLO restructuring; SRNE bankruptcyFebruary 13, 2023 | wsj.comSorrento Therapeutics Files for Bankruptcy to Halt $173 Million Licensing JudgmentsFebruary 13, 2023 | proactiveinvestors.comSorrento Therapeutics stock plummets more than 60% on news of bankruptcy filingFebruary 13, 2023 | markets.businessinsider.comSorrento Therapeutics Stock Is Sinking: What's Going On?February 13, 2023 | finance.yahoo.comSorrento Therapeutics Stock Nosedives After Filing Bankruptcy PaperworkFebruary 13, 2023 | finance.yahoo.comJoint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.February 13, 2023 | benzinga.comThinking about buying stock in Sorrento Therapeutics, Bed Bath & Beyond, C3.ai, Expion360, or SoundHound AI?February 13, 2023 | msn.comSorrento sheds 60% after bankruptcy filing (update)February 13, 2023 | finance.yahoo.comA Sorrento Therapeutics, Inc. (NASDAQ:SRNE) insider increased their holdings by 2.0% last yearFebruary 12, 2023 | finance.yahoo.comScilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., acquires rights to FDA-Approved ELYXYB™ in the U.S. and Canada for the acute treatment of migraineFebruary 10, 2023 | marketbeat.comSorrento Therapeutics, Inc. (NASDAQ:SRNE) Shares Bought by Victory Capital Management Inc.Victory Capital Management Inc. increased its holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 136.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 281,357 shares of the biopharmaceuticFebruary 9, 2023 | marketbeat.comSG Americas Securities LLC Has $84,000 Holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)SG Americas Securities LLC trimmed its position in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 87.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 53,722 shares of the biopharmaceuFebruary 3, 2023 | insidermonkey.com5 Hot Healthcare Stocks to Buy NowFebruary 3, 2023 | marketbeat.comRaymond James & Associates Increases Stock Holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)Raymond James & Associates boosted its stake in Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 65.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 257,319 shares of the biopharmaceutical company'February 3, 2023 | wsj.comSorrento Issues Supplement to its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common StockFebruary 2, 2023 | finance.yahoo.comSorrento Issues Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common StockFebruary 1, 2023 | marketbeat.comBarclays PLC Purchases 1,829,031 Shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE)Barclays PLC increased its position in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE - Get Rating) by 1,097.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,995,651 shares of the biopharmaceutical company's sJanuary 31, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Sorrento Therapeutics (SRNE), Aethlon Medical (AEMD) Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. SRNE Media Mentions By Week SRNE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRNE News Sentiment▼0.000.42▲Average Medical News Sentiment SRNE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRNE Articles This Week▼10▲SRNE Articles Average Week Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Creative Medical Technology News Today Titan Pharmaceuticals News Today Palisade Bio News Today Fresh Tracks Therapeutics News Today Inhibikase Therapeutics News Today Organovo News Today TRACON Pharmaceuticals News Today BioCardia News Today Genetic Technologies News Today TC Biopharm News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRNE) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
